Recently, Cai group (8) identified the role of ferroptosis in DCM, and reported that Nrf2 activation by sulforaphane inhibited ferroptosis and prevented DCM, suggesting that it is feasible to treat DCM by inhibiting ferroptosis. The gene discussed is NFE2L2; the disease is familial dilated cardiomyopathy.